Scarica l'app Stockscreener
0.2664
4.86%
-0.0136
Pre-mercato:
.27
0.0036
+1.35%
Precedente Chiudi:
$0.28
Aprire:
$0.28
Volume 24 ore:
5.42M
Relative Volume:
0.86
Capitalizzazione di mercato:
$242.78M
Reddito:
$420.00K
Utile/perdita netta:
$-35.84M
Rapporto P/E:
-0.0449
EPS:
-5.9381
Flusso di cassa netto:
$-32.12M
1 W Prestazione:
+2.26%
1M Prestazione:
-34.46%
6M Prestazione:
-98.55%
1 anno Prestazione:
-95.93%
Intervallo 1D:
$0.2598
$0.2831
Intervallo di 1 settimana:
$0.25
$0.51
Portata 52W:
$0.2325
$20.60
Kala Bio Inc Stock (KALA) Company Profile
Nome
Kala Bio Inc
Settore
Industria
Telefono
781-996-5252
Indirizzo
1167 MASSACHUSETTS AVENUE, ARLINGTON, MA
Compare KALA vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
KALA
Kala Bio Inc
|
0.2664 | 242.78M | 420.00K | -35.84M | -32.12M | -5.9381 |
|
VRTX
Vertex Pharmaceuticals Inc
|
466.10 | 118.41B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
756.91 | 80.02B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
703.30 | 43.52B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
318.91 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
289.65 | 32.13B | 5.36B | 287.73M | 924.18M | 2.5229 |
Kala Bio Inc Stock (KALA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-30 | Downgrade | Mizuho | Outperform → Neutral |
| 2025-09-29 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2025-09-29 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2025-09-08 | Iniziato | Mizuho | Outperform |
| 2025-07-11 | Iniziato | Ladenburg Thalmann | Buy |
| 2022-03-30 | Downgrade | JP Morgan | Neutral → Underweight |
| 2021-08-06 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-09-14 | Downgrade | Jefferies | Buy → Hold |
| 2020-07-23 | Iniziato | Northland Capital | Outperform |
| 2020-06-01 | Ripresa | Oppenheimer | Outperform |
| 2020-05-27 | Reiterato | H.C. Wainwright | Buy |
| 2020-03-09 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-12-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2019-03-14 | Iniziato | Jefferies | Buy |
Mostra tutto
Kala Bio Inc Borsa (KALA) Ultime notizie
Stock Trend Capital Highlights Younet AI’s Exclusive Biotech Partnership with KALA BIO - TipRanks
KALA BIO to launch first commercial AI agent in two weeks - Investing.com Nigeria
KALA BIO, Inc. (NASDAQ:KALA) Short Interest Update - MarketBeat
Why Did KALA Stock Surge 25% Today? - Stocktwits
Movement Recap: Does Dragonfly Energy Holdings Corp Equity Warrant have consistent dividend growthQuarterly Trade Report & Expert Curated Trade Ideas - baoquankhu1.vn
Morgan Stanley Smith Barney files Form 144 to sell restricted KALA shares (KALA) - Stock Titan
Highpeak Energy Posts Downbeat Q4 Results, Joins Netskope, Descartes Systems And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga
After Hours 11 Mar 2026: KALA BIO (KALA NASDAQ) up 24.16% to $0.36, model sees upside - Meyka
Younet.ai Highlights Researgency.ai Collaboration with Kala Bio (KALA) as New "AutoResearch" Milestone Signals the Rise of Autonomous Research Agents - TMX Newsfile
KALA BIO (KALA) Stock Jumps 70% After Pivoting to AI With ‘Palantir for Biotech’ Vision - MEXC
KALA BIO's 70% Surge: Flow Analysis of the AI Pivot - Bitget
Kala Bio Announces Launch Of First Commercial AI Product - marketscreener.com
KALA BIO (KALA) Stock Soars 70% on AI Agent Launch and ‘Palantir for Biotech’ Strategy - Blockonomi
Why Did KALA Stock Surge 70% In Pre-Market Today? - Asianet Newsable
Why Is Kala Bio Stock Soaring Wednesday?Kala Bio (NASDAQ:KALA) - Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
KALA Announces Launch of First AI Product, Revolutionizing Biote - GuruFocus
Kala Bio Launches a Revolution for Biotech- First AI Agent Deploying in 14 Days as $180 Billion Agentic AI Healthcare Revolution Accelerates - Bitget
Stock Trend Capital Provides Younet AI Investment Update - TMX Newsfile
Younet AI inks exclusive biotech platform deal with KALA BIO - Stock Titan
Dividend Watch: Will KALA BIO Inc benefit from sector rotationProduct Launch & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
$167 Billion Invested in Biotech R&D is Underserved by AI, Offering Huge Opportunity for New On-Premises AI Infrastructure Platform from KALA BIO, Inc. (Nasdaq: KALA) - Barchart.com
$167 Billion Invested in Biotech R&D is Underserved by AI, - openPR.com
Kala Bio Stock Soars 22% After Hours As Emergency Financing Deal Averts Asset Seizure After Eye Disease Drug Trial Collapse - Stocktwits
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
$167 Billion Pharma R&D Market Largely Untapped by AI Creates Major Growth Runway for KALA Bios Data-Sovereign AI Strategy: N A S D A Q: KALA - PRLog
User - The Chronicle-Journal
KALA Unveils AI Platform to Revolutionize Biotech Data Managemen - GuruFocus
KALA Bio launches on-premises AI platform for biotech sector By Investing.com - Investing.com Australia
What's Going On With KALA BIO Stock Wednesday?Kala Bio (NASDAQ:KALA) - Benzinga
KALA Bio launches on-premises AI platform for biotech sector - Investing.com Nigeria
Kala Bio, Inc Announces Exclusive License Agreement with Younet Ai for Proprietary Ai Research Platform - marketscreener.com
Kala Bio Launches AI Platform for Biotech Industry - Data Center Knowledge
KALA BIO Secures Exclusive Researgency AI Platform License - TipRanks
KALA BIO (NASDAQ: KALA) signs exclusive Researgency AI license and $55M Younet option - Stock Titan
KALA Surges 14% on AI Licensing Strategy - GuruFocus
Kala Bio rises on plans to leverage AI (KALA:NASDAQ) - Seeking Alpha
KALA BIO Announces Strategic Initiative to Deploy and Continue to Develop an On-Premises AI Infrastructure Platform for the Biotech Industry; Enters Into Platform Development and Exclusive License Agreement for Proprietary AI Research Platform 'Researge - The Manila Times
KALA BIO Announces Strategic Initiative to Deploy and Continue to Develop an On-Premises AI Infrastructure Platform for the Biotech Industry; Enters Into Platform Development and Exclusive License Agreement for Proprietary AI Research Platform - ChartMill
KALA BIO, Inc. (NASDAQ:KALA) Given Average Rating of "Hold" by Analysts - MarketBeat
KALA Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Kala Bio (KALA) Stock Analysis Report | Financials & Insights - Benzinga Japan
Brendan P. Purdy Net Worth (2026) - GuruFocus
Hillel D. Posen Net Worth (2026) - GuruFocus
Comparing KALA BIO (NASDAQ:KALA) and Adagene (NASDAQ:ADAG) - Defense World
David Lazar resigns from KALA BIO board - TradingView
Why KALA BIO Inc. stock could benefit from AI revolutionQuarterly Portfolio Report & Smart Allocation Stock Tips - mfd.ru
Can KALA BIO Inc. withstand a market correction2025 Major Catalysts & Advanced Technical Analysis Signals - mfd.ru
Director David Lazar resigns from KALA BIO (NASDAQ: KALA) board - Stock Titan
Baker Bros. discloses 9.99% KALA BIO (KALA) stake via convertible preferred - Stock Titan
MSN Money - MSN
Kala Bio Inc Azioni (KALA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.99%
0.71%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):